Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention

Journal of Clinical Investigation

Volumn 103, Issue 9, 1999, Pages 1237-1241

  Stetler Stevenson, William G ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Laboratory of Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE;

ANGIOGENESIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0033134622     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6870     Document Type: Review

References (24)

1. Murphy, A.N., Unsworth, E.J., and Stetler-Stevenson, W.G. 1993. Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157:351-358.
2. Anand-Apte, B., et al. 1997. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38:817-823.
3. Benelli, R., et al. 1994. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol. Res. 6:251-257.
4. Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R., and Weiss, S.J. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:365-377.
5. Vu, T.H., et al. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:411-422.
6. Itoh, T., et al. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048-1051.
7. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:439-442.
8. Schnaper, H.W., et al. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156:235-246.
9. Haas, T.L., Davis, S.J., and Madri, J.A. 1998. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273:3604-3610.
10. Will, H., Atkinson, S.J., Butler, G.S., Smith, B., and Murphy, G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates auto-proteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271:17119-17123.
11. Overall, CM., et al. 1999. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase a by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV. J. Biol. Chem. 274:4421-4429.
12. Kheradmand, F., Werner, E., Tremble, P., Symons, M., and Werb, Z. 1998. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 280:898-902.
13. Brooks, P.C., Silletti, S., von Schalscha, T.L., Friedlander, M., and Cheresh, D.A. 1998. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 92:391-400.
14. Brooks, P.C., et al. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell. 85:683-693.
15. Olson, M.W., Gervasi, D.C., Mobashery, S., and Fridman, R. 1997. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272:29975-29983.
16. Bafetti, L.M., Young, T.N., Itoh, Y., and Stack, M.S. 1998. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem. 273:143-149.
17. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W.G., and Quaranta, V. 1997. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 277:225-228.
18. Scatena, M., et al. 1998. NFκB mediates αvβ3 integrin-induced endothelial cell survival. J. Cell Biol. 141:1083-1093.
19. Mari, B.P., et al. 1998. Stromelysin-3 is induced in tumor/stroma cocultures and inactivated via a tumor-specific and basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273:618-626.
20. Whitelock, J.M., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A. 1996. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271:10079-10086.
21. Cornelius, L.A., et al. 1998. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161:6845-6852.
22. Patterson, B.C., and Sang, Q.A. 1997. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272:28823-28825.
23. Dong, Z.Y., Kumar, R., Yang, X.L., and Fidler, I.J. 1997. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88:801-810.
24. O'Reilly, M.S., et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277-285.